F2 and COVID-19: In a previous study of our group (Ceballos et al., 2021), we analyzed poorly studied coagulation proteins such as antithrombin, prothrombin, factor XI, factor XII, and factor XIII, which were differently affected at the first stages of COVID-19 depending on the degree of the disease.